VARIATION AND REGULATION OF ALTERNATIVE SPLICING IN HUMAN TRANSCRIPTOMES
人类转录组中选择性剪接的变异和调控
基本信息
- 批准号:9912772
- 负责人:
- 金额:$ 36.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-04-05 至 2023-03-31
- 项目状态:已结题
- 来源:
- 关键词:AllelesAlternative SplicingBiological AssayCellsChromatinComplementComplexComputer AnalysisComputing MethodologiesDataData SetDepositionDevelopmentDisciplineDiseaseDisease susceptibilityEpigenetic ProcessEukaryotic CellEvolutionExonsFundingGene Expression RegulationGenesGenetic TranscriptionGenetic VariationGenomeGenotype-Tissue Expression ProjectHumanIndividualIntronsJointsKnowledgeMapsMessenger RNAMethodsMolecularPathogenesisPatternPhenotypePopulationPrimatesProtein IsoformsPublic DomainsQuantitative Trait LociRNARNA SplicingRNA-Protein InteractionRegulationRegulatory ElementResearchResearch ActivitySignal TransductionStatistical MethodsTechnologyTestingTranscription ElongationVariantWorkcell typecomputer studiescomputerized toolscrosslinking and immunoprecipitation sequencingepigenetic regulationepigenomeepigenomicsexperimental studygene functiongenomic toolshuman tissueimprovedindividual variationinnovationinsightinterestmRNA Precursornovelresponsetraittranscriptometranscriptome sequencing
项目摘要
PROJECT SUMMARY
The central objective of this renewal R01 project is to elucidate the variation and regulation of alternative
splicing (AS) in human transcriptomes. Eukaryotic cells generate astonishing regulatory diversity and complex
phenotypes from a finite set of genes. AS of precursor mRNA is a mechanism essential for generating this
regulatory diversity. Almost all multi-exon human genes are alternatively spliced. Widespread changes in AS
occur between species, within human populations, in response to developmental signals and environmental
perturbations, and in disease pathogenesis. Despite the importance of AS in gene regulation and disease, as
well as extensive interest and research activities in this field, there remain many open questions and significant
knowledge gaps regarding the landscape, regulation, and functional consequence of AS variation in human
transcriptomes. Powerful sequencing technologies for characterizing transcriptome complexity (RNA-seq) and
protein-RNA interaction (CLIP-seq), as well as the vast amounts of data continuously deposited into the public
domain, create exciting and unprecedented opportunities for studies of AS. This proposal integrates data-
driven research leveraging big transcriptome data with hypothesis-driven research using molecular and
genomic tools. In three aims, we will investigate the evolution of AS in primates
(Aim 1), the genetic variation
and phenotypic association of AS in human populations (Aim 2), and epigenetic regulation of AS across human
tissues and cell states (Aim 3).
We will also develop and disseminate innovative computational and statistical
methods for analyzing AS using large, heterogeneous sequencing datasets. As in our previous funding cycle,
we will tap into our extensive network of expert collaborators to amplify the impact of our work and pursue new
research opportunities within and beyond the scope of the proposed project. Collectively, our research will
generate significant novel insights into the variation, regulation, and function of AS, and create broadly
applicable computational tools for studying AS variation and mRNA isoform complexity in diverse biomedical
disciplines.
项目摘要
该更新R01项目的核心目的是阐明替代方案的变化和调节
人类转录组中的剪接(AS)。真核细胞产生惊人的调节多样性和复杂性
来自有限基因的表型。从前体mRNA开始是产生此机制的一种机制
监管多样性。几乎所有的多外结果人类基因都是剪接的。广泛的变化AS
响应于发展信号和环境的物种之间的物种之间发生
扰动和疾病发病机理。尽管在基因调节和疾病中很重要,但
以及该领域的广泛兴趣和研究活动,还有许多开放问题和重大的问题
关于人类变异的景观,调节和功能后果的知识差距
转录组。强大的测序技术来表征转录组复杂性(RNA-SEQ)和
蛋白-RNA相互作用(夹子seq),以及不断沉积在公众中的大量数据
域,创造令人兴奋且前所未有的AS研究机会。该提案整合了数据 -
通过使用分子和
基因组工具。在三个目标中,我们将研究灵长类动物的AS的演变
(AIM 1),遗传变异
与人类种群中的AS(AIM 2)和AS的表观遗传调节
组织和细胞状态(AIM 3)。
我们还将开发和传播创新的计算和统计
分析使用大型异质测序数据集的方法。就像我们以前的资金周期一样
我们将利用我们广泛的专家合作者网络来扩大我们的工作影响并追求新
拟议项目范围内外的研究机会。总的来说,我们的研究将
对AS的变化,调节和功能产生重大的新颖见解,并广泛创建
用于研究的适用计算工具,以变异和mRNA同工型复杂性
学科。
项目成果
期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
CLIP-seq analysis of multi-mapped reads discovers novel functional RNA regulatory sites in the human transcriptome.
- DOI:10.1093/nar/gkx646
- 发表时间:2017-09-19
- 期刊:
- 影响因子:14.9
- 作者:Zhang Z;Xing Y
- 通讯作者:Xing Y
Genetic variation of pre-mRNA alternative splicing in human populations.
- DOI:10.1002/wrna.120
- 发表时间:2012-07
- 期刊:
- 影响因子:7.3
- 作者:Lu, Zhi-Xiang;Jiang, Peng;Xing, Yi
- 通讯作者:Xing, Yi
SURVIV for survival analysis of mRNA isoform variation.
- DOI:10.1038/ncomms11548
- 发表时间:2016-06-09
- 期刊:
- 影响因子:16.6
- 作者:Shen S;Wang Y;Wang C;Wu YN;Xing Y
- 通讯作者:Xing Y
PrimerSeq: Design and visualization of RT-PCR primers for alternative splicing using RNA-seq data.
- DOI:10.1016/j.gpb.2014.04.001
- 发表时间:2014-04
- 期刊:
- 影响因子:9.5
- 作者:Tokheim, Collin;Park, Juw Won;Xing, Yi
- 通讯作者:Xing, Yi
Deep-learning augmented RNA-seq analysis of transcript splicing.
- DOI:10.1038/s41592-019-0351-9
- 发表时间:2019-04
- 期刊:
- 影响因子:48
- 作者:Zhang Z;Pan Z;Ying Y;Xie Z;Adhikari S;Phillips J;Carstens RP;Black DL;Wu Y;Xing Y
- 通讯作者:Xing Y
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yi Xing其他文献
Yi Xing的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yi Xing', 18)}}的其他基金
Computational tools and resources to study alternative splicing and mRNA isoform variation
研究选择性剪接和 mRNA 亚型变异的计算工具和资源
- 批准号:
10669330 - 财政年份:2022
- 资助金额:
$ 36.96万 - 项目类别:
ProteoSeq - An Integrative Computational Framework for Proteotranscriptomics
ProteoSeq - 蛋白质转录组学的综合计算框架
- 批准号:
9193233 - 财政年份:2016
- 资助金额:
$ 36.96万 - 项目类别:
ProteoSeq - An Integrative Computational Framework for Proteotranscriptomics
ProteoSeq - 蛋白质转录组学的综合计算框架
- 批准号:
9342975 - 财政年份:2016
- 资助金额:
$ 36.96万 - 项目类别:
Evolution of Pre-mRNA Splicing in Primates
灵长类动物中前体 mRNA 剪接的进化
- 批准号:
8643793 - 财政年份:2010
- 资助金额:
$ 36.96万 - 项目类别:
Evolution of Pre-mRNA Splicing in Primates
灵长类动物中前体 mRNA 剪接的进化
- 批准号:
8248784 - 财政年份:2010
- 资助金额:
$ 36.96万 - 项目类别:
Evolution of Pre-mRNA Splicing in Primates
灵长类动物中前体 mRNA 剪接的进化
- 批准号:
8055497 - 财政年份:2010
- 资助金额:
$ 36.96万 - 项目类别:
Variation and regulation of alternative splicing in human transcriptomes
人类转录组选择性剪接的变异和调控
- 批准号:
9333758 - 财政年份:2010
- 资助金额:
$ 36.96万 - 项目类别:
Evolution of Pre-mRNA Splicing in Primates
灵长类动物中前体 mRNA 剪接的进化
- 批准号:
8606617 - 财政年份:2010
- 资助金额:
$ 36.96万 - 项目类别:
Evolution of Pre-mRNA Splicing in Primates
灵长类动物中前体 mRNA 剪接的进化
- 批准号:
7887167 - 财政年份:2010
- 资助金额:
$ 36.96万 - 项目类别:
Evolution of Pre-mRNA Splicing in Primates
灵长类动物中前体 mRNA 剪接的进化
- 批准号:
8441566 - 财政年份:2010
- 资助金额:
$ 36.96万 - 项目类别:
相似国自然基金
5'-tRF-GlyGCC通过SRSF1调控RNA可变剪切促三阴性乳腺癌作用机制及干预策略
- 批准号:82372743
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
MEK/ERK通路对Bim选择性剪接的调节及其在胃癌细胞对化疗敏感性中作用
- 批准号:81071809
- 批准年份:2010
- 资助金额:33.0 万元
- 项目类别:面上项目
Dyrk1A调控CaMKⅡδ的可变剪接及其在心脏重构过程中的作用
- 批准号:30971223
- 批准年份:2009
- 资助金额:31.0 万元
- 项目类别:面上项目
相似海外基金
The mechanism of CELF1 upregulation and its role in the pathogenesis of Myotonic Dystrophy Type 1
CELF1上调机制及其在强直性肌营养不良1型发病机制中的作用
- 批准号:
10752274 - 财政年份:2024
- 资助金额:
$ 36.96万 - 项目类别:
Long Noncoding RNA H19 Mediating Alternative Splicing in ALD Pathogenesis
长非编码 RNA H19 介导 ALD 发病机制中的选择性剪接
- 批准号:
10717440 - 财政年份:2023
- 资助金额:
$ 36.96万 - 项目类别:
Mapping tumor specific immunopeptidome for antibody-based targeted therapy
绘制肿瘤特异性免疫肽组用于基于抗体的靶向治疗
- 批准号:
10604941 - 财政年份:2023
- 资助金额:
$ 36.96万 - 项目类别:
Mechanisms that Enhance and Suppress HIV-1 Resistance in Gene Edited Primary Human Cells
增强和抑制基因编辑原代人类细胞中 HIV-1 耐药性的机制
- 批准号:
10700726 - 财政年份:2023
- 资助金额:
$ 36.96万 - 项目类别:
MBNL loss of function in visceral smooth muscle as a model of myotonic dystrophy type 1
MBNL 内脏平滑肌功能丧失作为 1 型强直性肌营养不良模型
- 批准号:
10605562 - 财政年份:2022
- 资助金额:
$ 36.96万 - 项目类别: